Fingerprint
Dive into the research topics of 'Abstract CT331: Phase I/II trial of a novel antibody DNA immunotherapy, targeting CD64, in the treatment of Melanoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Abstract CT331: Phase I/II trial of a novel antibody DNA immunotherapy, targeting CD64, in the treatment of Melanoma
Lindy G Durrant, Christian Ottensmeier, Paul Lorigan, Clive Mulatero, Ruth Plummer, Michelle Cunell, Rachael L Metheringham, Victoria A Brentville, Lee Machado
Research output: Contribution to Conference › Abstract